Versigent (NYSE:VGNT) Coverage Initiated at TD Cowen

Stock analysts at TD Cowen began coverage on shares of Versigent (NYSE:VGNT) in a research note issued to investors on Tuesday, Marketbeat reports. The brokerage set a “buy” rating and a $47.00 price target on the stock. TD Cowen’s price objective points to a potential upside of 36.98% from the company’s current price.

A number of other research analysts have also commented on VGNT. Fox Advisors upgraded Versigent to a “strong-buy” rating in a report on Tuesday, April 7th. Royal Bank Of Canada started coverage on shares of Versigent in a research note on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 price objective on the stock. Wells Fargo & Company initiated coverage on shares of Versigent in a research report on Monday, April 6th. They set an “overweight” rating and a $35.00 target price on the stock. Finally, UBS Group initiated coverage on shares of Versigent in a research note on Tuesday. They set a “buy” rating and a $43.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Versigent has an average rating of “Buy” and a consensus target price of $38.25.

Versigent Stock Performance

Shares of NYSE:VGNT opened at $34.31 on Tuesday. Versigent has a twelve month low of $26.34 and a twelve month high of $34.99.